Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Mechanisms of Ageing and Development|October 20, 2024
Impact of senescence cell signature in patients with non-small cell carcinoma and melanoma receiving PD-L1/PD-1 inhibitorsYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.Translational Lung Cancer Research|March 15, 2021
An immune-related gene expression signature predicts brain metastasis in lung adenocarcinoma patients after surgery: gene expression profile and immunohistochemical analysesYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.Anticancer Research|January 31, 2025
Immunosuppressive State May Lead to Brain Metastases in Lung Squamous Cell Carcinoma: Gene Expression and Immunohistochemical AnalysisYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.Frontiers in Oncology|December 8, 2022
Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinomaYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.Thoracic Cancer|March 21, 2022
Assessment of textbook outcome after lobectomy for early-stage non-small cell lung cancer in a Korean institution: A retrospective studyWoo Sik Yu, Jaeyong Shin, Jung A Son, et al.Journal of Chest Surgery|December 15, 2021
A Complication of Diaphragm Repair Using a Gore-Tex (Expanded Polytetrafluorethylene) Membrane: A Case ReportSeungwook Lee, Sung Yeon Hong, Jung A Son, et al.Journal of Thoracic Disease|March 10, 2017
Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patientsSeong Yong Park, Joon-Kee Yoon, Su Jin Lee, et al.The Korean Journal of Thoracic and Cardiovascular Surgery|April 18, 2018
Pulmonary Nodular Lymphoid Hyperplasia in a 33-Year-Old WomanJi Ye Park, Seong Yong Park, Seokjin Haam, et al.Journal of Thoracic Disease|May 13, 2024
Subnormothermic ex vivo lung perfusion possibly protects against ischemia-reperfusion injury via the mTORC-HIF-1α pathwayJee Won Suh, Soo Jin Park, Young Wha Koh, et al.Oncoimmunology|October 25, 2019
Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patientsYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.Pageof 6